Skip to main content
OpenTrials

Clinical trial condition

Lymphoma

Explore clinical trials studying Lymphoma. Study availability and eligibility vary by location and protocol.

3,652 public trials 850 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma trial results

Completed

Immune Responses to COVID-19 Vaccination in Lymphoma Patients

NCT04858568

Conditions
Burkitt Lymphoma, Chronic Disease, Chronic Lymphocytic Leukemia, +42 more
Locations
  • Bedfordshire Hospitals NHS Foundation Trust Bedford, Bedfordshire, United Kingdom
  • Portsmouth Hospitals University NHS Trust Portsmouth, Hampshire, United Kingdom
  • University Hospital Southampton NHS Foundation Trust Southampton, Hampshire, United Kingdom
  • Wye Valley NHS Trust Hereford, Herefordshire, United Kingdom
View Trial Details
Completed

A Phase 1b Open-Label Study Investigating the Safety and Pharmacokinetics of Administration of Subcutaneous Blinatumomab for the Treatment of Relapsed/Refractory Indolent Non-Hodgkin's Lymphoma

NCT02961881

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • Rush University Medical Center Chicago, Illinois, United States
  • Hackensack University Medical Center Hackensack, New Jersey, United States
  • Concord Repatriation General Hospital Concord, New South Wales, Australia
View all 17 locations
View Trial Details
Completed

PROCLAIM-CX-2029: A Trial to Find Safe and Active Doses of an Investigational Drug CX-2029 for Patients With Solid Tumors or DLBCL

NCT03543813

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +29 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • California Cancer Associates for Research and Excellence Encinitas, California, United States
  • University of Southern California Los Angeles, California, United States
  • Yale Cancer Center New Haven, Connecticut, United States
View all 25 locations
View Trial Details
Completed

Compare Efficacy, Safety, and Immunogenicity of Proposed Rituximab Biosimilar (DRL_RI) With MabThera® in LTB Follicular Lymphoma

NCT03976102

Conditions
Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations
  • The Oncology Institute of Hope and Innovation Whittier, California, United States
  • American Oncology Partners of Maryland Bethesda, Maryland, United States
  • University of Tennessee Medical Center - Cancer Institute Knoxville, Tennessee, United States
  • Gulf coast Oncology Associates, PA Houston, Texas, United States
View Trial Details
Completed

My Choices: Efficacy and Implementation Study

NCT05358613

Conditions
Alcohol Drinking, Alcohol Use Disorder, Mild, Alcohol Use, Unspecified, +17 more
Locations
  • Centre Intégré Universitaire de Santé et de Services Sociaux du Saguenay-Lac-Saint-Jean Jonquière, Quebec, Canada
  • Centre Intégré de Santé Services Sociaux de Laval Laval, Quebec, Canada
  • Centre intégré de Santé et de Services Sociaux de Chaudière-Appalaches Lévis, Quebec, Canada
  • Centre Intégré Universitaire de Santé et de Services Sociaux de la Capitale-Nationale Québec, Canada
View Trial Details

Related conditions